Clinical aspects of neuroimmunology, by Edward A. Neuwelt and W. Kemp Clark, The Williams and Wilkins Company, Baltimore, 1978, 277 pp, illustrated, $35.00

1980 ◽  
Vol 7 (4) ◽  
pp. 394-394
Author(s):  
Richard T. Johnson
Keyword(s):  
Clinical Aspects ◽  
Wilkins Company

ABO Haemolytic Disease of the Newborn, by E. R. Gold, M.D. and N. R. Butler, M.D., F.R.C.P., D.C.H. Baltimore: The Williams & Wilkins Company, 1972, 212 pp., $15.75

PEDIATRICS ◽  
1974 ◽  
Vol 53 (4) ◽  
pp. 593-593
Author(s):  
Jerold F. Lucey
Keyword(s):  
The Other ◽  
Clinical Aspects ◽  
Hemolytic Disease ◽  
Haemolytic Disease ◽  
Source Book ◽  
Abo Incompatibility ◽  
Laboratory Techniques ◽  
History Of ◽  
Staff Research ◽  
Wilkins Company

This is a compact, up-to-date (1972), thorough, source book. It contains more information on ABO incompatibility than most physicians need or may want to know. Approximately one third of the book's 212 pages are devoted to clinical aspects of the problem. The other two thirds is concerned with serology, laboratory techniques, and the history of hemolytic disease. The book is clearly written and would be particularly appropriate for house staff, research fellows, and consulting physicians who want a concise, accurate, authoritative reference.

Clinical aspects of reactive oxygen and nitrogen species

2004 ◽  
Vol 71 ◽  
pp. 121-133 ◽  
Author(s):  
Ascan Warnholtz ◽  
Maria Wendt ◽  
Michael August ◽  
Thomas Münzel
Keyword(s):  
Oxidative Stress ◽  
Reactive Oxygen Species ◽  
Risk Factor ◽  
Endothelial Dysfunction ◽  
Vascular Tissue ◽  
Rapid Development ◽  
Reactive Oxygen ◽  
Clinical Aspects ◽  
No Production ◽  
Oxygen Species

Endothelial dysfunction in the setting of cardiovascular risk factors, such as hypercholesterolaemia, hypertension, diabetes mellitus and chronic smoking, as well as in the setting of heart failure, has been shown to be at least partly dependent on the production of reactive oxygen species in endothelial and/or smooth muscle cells and the adventitia, and the subsequent decrease in vascular bioavailability of NO. Superoxide-producing enzymes involved in increased oxidative stress within vascular tissue include NAD(P)H-oxidase, xanthine oxidase and endothelial nitric oxide synthase in an uncoupled state. Recent studies indicate that endothelial dysfunction of peripheral and coronary resistance and conductance vessels represents a strong and independent risk factor for future cardiovascular events. Ways to reduce endothelial dysfunction include risk-factor modification and treatment with substances that have been shown to reduce oxidative stress and, simultaneously, to stimulate endothelial NO production, such as inhibitors of angiotensin-converting enzyme or the statins. In contrast, in conditions where increased production of reactive oxygen species, such as superoxide, in vascular tissue is established, treatment with NO, e.g. via administration of nitroglycerin, results in a rapid development of endothelial dysfunction, which may worsen the prognosis in patients with established coronary artery disease.

Clinical Aspects of the Hepatic Circulation

1965 ◽  
Vol 48 (6) ◽  
pp. 790-804 ◽  
Author(s):  
Carroll M. Leevy
Keyword(s):  
Clinical Aspects ◽  
Hepatic Circulation

Noninvasive Assessment of Coronary Artery Disease – Anatomical versus Functional Imaging and the Marginal Role of Exercise Electrocardiograms

Praxis ◽  
2020 ◽  
Vol 109 (14) ◽  
pp. 1141-1149
Author(s):  
Martina Boscolo Berto ◽  
Dominik C. Benz ◽  
Christoph Gräni
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Functional Imaging ◽  
Clinical Aspects ◽  
Industrialized Countries ◽  
Coronary Syndromes ◽  
Pros And Cons ◽  
Noninvasive Assessment ◽  
Artery Disease ◽  
European Society Of Cardiology

Abstract. Coronary artery disease (CAD) is the leading cause of morbidity and mortality in the industrialized countries. Assessment of symptomatic patients with suspected obstructive CAD is a common reason for a clinical visit. Noninvasive anatomical and functional imaging are established tools to rule-in and rule-out CAD, to assess the severity of disease and to determine the potential risk of future cardiovascular events. In this review, we discuss the updated Guidelines from the European Society of Cardiology on Chronic Coronary Syndromes and explore the different imaging modalities used in current clinical practice for the noninvasive assessment of CAD. The pros and cons of each method, especially comparing anatomical and functional testing, are presented. Furthermore we we address the practical clinical aspects in the selection of the optimal noninvasive tests according to clinical need.

Sign in / Sign up

Export Citation Format

Share Document